In human hepatocellular carcinoma (HCC), chelerythrine (2) can inhibit human hepatocellular carcinoma Hep3B cells by downregulating the expression of p-FAK and MMP-2/9. This evidence concerns the gene PTK2 and hepatocellular carcinoma.